Home News J&J to buy cardio technology company Abiomed for $16.6B J&J to buy cardio technology company Abiomed for $16.6BNovember 2, 2022News The Johnson & Johnson logo appears above a trading post on the floor of the New York Stock Exchange, Monday, July 12, 2021. Richard Drew Tom Murphy AP Health Writer Johnson & Johnson is spending more than $16 billion to move deeper into treating heart disease and continue a shift… Login to continue reading Login Sign up for complimentary access Sign Up Now Close Previous Post As political ads flood the Oklahoma governor race, The Frontier checked the facts Next Post Halloween Fun in the Depot District Featured Local Savings -
Foundation issues plague SouthernTech aviation facility: Floor heaving due to underground waterOctober 31, 2025
